Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 4
2005 6
2006 6
2007 2
2008 3
2009 2
2010 2
2011 4
2012 9
2013 5
2014 3
2015 4
2016 2
2017 2
2018 3
2019 4
2020 4
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Letter to the Editor.
Hannouf MB, Muzzey D, Kronenwett R, Lancaster JM. Hannouf MB, et al. Among authors: kronenwett r. J Comp Eff Res. 2019 Nov;8(15):1257-1259. doi: 10.2217/cer-2019-0050. Epub 2019 Nov 19. J Comp Eff Res. 2019. PMID: 31741394 Free article. No abstract available.
Molecular biology of hematopoietic stem cells.
Steidl U, Kronenwett R, Martin S, Haas R. Steidl U, et al. Among authors: kronenwett r. Vitam Horm. 2003;66:1-28. doi: 10.1016/s0083-6729(03)01001-x. Vitam Horm. 2003. PMID: 12852251 Review.
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer.
Constantinidou A, Marcou Y, Toss MS, Simmons T, Bernhisel R, Hughes E, Probst B, Meek S, Kakouri E, Georgiou G, Zouvani I, Savvidou G, Kuhl V, Doedt J, Wagner S, Gutin A, Slavin TP, Lanchbury JS, Kronenwett R, Ellis IO, Rakha EA. Constantinidou A, et al. Among authors: kronenwett r. Clin Cancer Res. 2022 Oct 14;28(20):4435-4443. doi: 10.1158/1078-0432.CCR-22-0619. Clin Cancer Res. 2022. PMID: 36043530 Free PMC article.
Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer.
Kuhl V, Clegg W, Meek S, Lenz L, Flake DD 2nd, Ronan T, Kornilov M, Horsch D, Scheer M, Farber D, Zalaznick H, Cussenot O, Compérat E, Cancel-Tassin G, Wild PJ, Chun FK, Mandel P, Moinfar F, Cohen T, Delee S, Kronenwett R, Doedt J. Kuhl V, et al. Among authors: kronenwett r. Biomark Med. 2022 Apr;16(6):449-459. doi: 10.2217/bmm-2021-0479. Epub 2022 Mar 24. Biomark Med. 2022. PMID: 35321552 Free article.
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict).
Jank P, Lindner JL, Lehmann A, Pfitzner BM, Blohmer JU, Horst D, Kronenwett R, Denkert C, Schmitt WD. Jank P, et al. Among authors: kronenwett r. Breast Cancer Res Treat. 2022 Jan;191(2):327-333. doi: 10.1007/s10549-021-06415-0. Epub 2021 Nov 16. Breast Cancer Res Treat. 2022. PMID: 34783927 Free PMC article.
72 results